Pangaea Oncology, S.A. (BME:PANG)
Spain · Delayed Price · Currency is EUR 1.700
-0.060 (-3.53%)
Apr 7, 2026, 4:00 PM CET
Pangaea Oncology Market Cap
Pangaea Oncology has a market cap or net worth of €61.43 million as of April 7, 2026. Its market cap has increased by 5.18% in one year.
Market Cap
61.43M
Enterprise Value
64.11M
Revenue
14.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.70
Market Cap Chart
Since December 29, 2016, Pangaea Oncology's market cap has increased from 30.03M to 61.43M, an increase of 104.58%. That is a compound annual growth rate of 8.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 61.43M | 3.35% |
| Dec 31, 2025 | 59.44M | -2.26% |
| Dec 31, 2024 | 60.81M | 12.24% |
| Dec 29, 2023 | 54.18M | 8.35% |
| Dec 30, 2022 | 50.00M | 41.34% |
| Dec 30, 2021 | 35.38M | 30.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.72B |
| Laboratorios Farmaceuticos Rovi | 4.14B |
| Almirall | 2.65B |
| Pharma Mar | 1.49B |
| Atrys Health | 217.76M |
| Prim, S.A. | 216.95M |
| Oryzon Genomics | 216.26M |
| Laboratorio Reig Jofre | 204.34M |